- Home
- BIPC vs LGND Comparison
BIPC vs LGND Comparison
Compare BIPC & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BIPC | LGND |
|---|---|---|
| Founded | 2019 | 1987 |
| Country | United States | United States |
| Employees | N/A | 68 |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 3.7B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | BIPC | LGND |
|---|---|---|
| Price | $40.41 | $255.54 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $45.00 | ★ $256.29 |
| AVG Volume (30 Days) | ★ 975.7K | 159.7K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 5.13% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.85 | $1.25 |
| Revenue Next Year | $5.94 | $19.41 |
| P/E Ratio | ★ N/A | $76.27 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $34.18 | $111.72 |
| 52 Week High | $51.72 | $258.57 |
Technical Indicators
Market Signals| Indicator | BIPC | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 45.04 | 72.06 |
| Support Level | $39.00 | $199.97 |
| Resistance Level | $41.08 | N/A |
| Average True Range (ATR) | 1.11 | 7.35 |
| MACD | -0.13 | 2.29 |
| Stochastic Oscillator | 0.40 | 86.05 |
Price Performance
Historical ComparisonAbout BIPC Brookfield Infrastructure Corporation
Brookfield Infrastructure Corp is an indirect subsidiary of the partnership of the diversified infrastructure owner and operators. Its business is comprised of a U.K. regulated distribution operation, a Brazilian regulated natural gas transmission operation and an international intermodal logistics operation. Geographically, the company generates a majority of its revenue from Brazil and rest from United Kingdom, United States, France, Switzerland, Singapore, China, Denmark, Hong Kong, Germany and Others.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.